Oxford University develops new vaccine for Bundibugyo Ebola

Source:BBC

02 — Who / Subject

Oxford University, Serum Institute of India

03 — Where / Locus

United Kingdom, Democratic Republic of Congo

04 — When / Temporality

May 22, 2026

Verified: May 22, 2026

05 — Why / Core Summary

"Oxford scientists are developing a vaccine for the Bundibugyo Ebola species. Clinical trials could begin in two to three months, pending animal research. The outbreak has caused 750 suspected cases and 177 deaths."

Conflict Analysis

Scientific development report on vaccine research for a specific Ebola strain.

Recommended Background Resource

Affiliate / AdAI Curation

The Coming Plague: Newly Emerging Diseases in a World Out of Balance

Author: Laurie Garrett

This classic work provides a comprehensive look at how emerging viral threats like Ebola interact with global ecosystems and human development, offering essential context for why vaccine development is critical in the face of recurring outbreaks.

Explore Background Book (Amazon)

As an Amazon Associate, COMPAMIR earns from qualifying purchases.

Post